Year: 2026

Freudenberg has obtained all required regulatory approvals related to its voluntary takeover offer for Nilfisk Holding A/S

Written by Customer Service on March 27, 2026. Posted in Mergers And Acquisitions.

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO ANY JURISDICTION IN WHICH DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL Freudenberg has obtained all required regulatory approvals related to its voluntary takeover offer for Nilfisk Holding A/S Following announcement no. 1/2026 of 7 January 2026 and announcement no. 4/2026 of 19 February 2026 regarding the voluntary takeover offer made by Freudenberg Home and Cleaning Solutions GmbH (the Offeror), a part of the German family-owned Freudenberg group (the Offeror Group), to acquire all of the issued and outstanding shares (except for treasury shares and shared held by the Offeror) in Nilfisk Holding A/S (Nilfisk) as described in the offer document (the Offer) (the Offer Document), the Offeror today announced that all regulatory approvals, waivers and notifications required...

Global study shows energy industry ramping up investment in autonomous operations by 2030 as AI reshapes performance

Written by Customer Service on March 27, 2026. Posted in Public Companies.

Schneider Electric Smart FactorySchneider Electric smart factory, LexingtonStudy of 400 senior energy and chemicals leaders across 12 countries signals a tipping point: the sector is racing towards almost 50% full automation by 2030 with close to a third of operations already fully autonomous 59% warn that delaying adoption will drive up operating costs, as the sector races to manage inflation and a retiring workforce Gulf Cooperation Council (GCC) and Asia lead on current adoptions levels with North America planning the most aggressive acceleration, fueled by AI-driven energy demand and expanding data center footprintHOUSTON, March 27, 2026 (GLOBE NEWSWIRE) — Schneider Electric, a global energy technology leader, today unveils new research highlighting a powerful combination of pressures pushing autonomous operations...

Annual General Meeting in cBrain A/S

Written by Customer Service on March 27, 2026. Posted in Public Companies.

Company Announcement no. 05/2026 Annual General Meeting 2026 Copenhagen, March 27, 2026 Annual General Meeting in cBrain A/SWednesday, April 29, 2026 at 16:00 CEST The meeting takes place at the Company’s address, Kalkbrænderiløbskaj, 2, 2100 Copenhagen Ø. Agenda 1) The Board of Directors’ report on the Company’s activities in the past year 2) Presentation of the audited annual report for adoption and resolution regarding discharge for the Management and the Board of Directors 3) Decision on appropriation of profit or covering of loss according to the approved annual report. 4) Election of members to the Board of Directors In accordance with the Company’s Articles of Association article 11.1, all board members are up for election. The Board of Directors proposes re-election of the following members:Henrik Hvidtfeldt (chair) Lisa...

Borregaard ASA: Proxies for the Annual General Meeting 16 April 2026

Written by Customer Service on March 27, 2026. Posted in Public Companies.

In connection with Borregaard’s Annual General Meeting, Mr. Helge Aasen, Chair of the Board of Directors in Borregaard ASA, has been assigned voting rights based on proxies for 7,906,608 shares in Borregaard ASA. The proxies apply exclusively to the Annual General Meeting in Borregaard ASA on 16 April 2026. This means that Mr. Helge Aasen represents a total of 7,9% of the outstanding shares in Borregaard ASA. Mr. Helge Aasen’s shareholding in Borregaard ASA is 4,500 shares. Borregaard ASASarpsborg, 27 March 2026 Contact: Lotte Kvinlaug, Investor Relations Officer, +47 922 86 909 This information is subject to the disclosure requirements pursuant to Section 5 -12 of the Norwegian Securities Trading Act.

Vantiva – Estimated Operational Results Full Year 2025

Written by Customer Service on March 27, 2026. Posted in Earnings Releases And Operating Results.

Press Release Estimated Operational Results Full Year 2025 Vantiva meets its guidance at the budget forex rate ADJUSTED EBITDA: €145 MILLION vs €109 million in 20241(€155 MILLION at budget forex rate)FCF2 POSITIVE: €62 MILLION vs -€25 million in 2024(€71 MILLION at budget forex rate) Paris (France) – March 27, 2026 – Vantiva (Euronext Paris: VANTI), a global technology leader in connectivity, announces its estimated unaudited operational results for the year 2025. The accounting basis used for these estimates is consistent with the accounting methods applied by Vantiva and described in its consolidated financial statements. However, since some annual closing procedures for 2025 are not yet completed, the auditors’ opinion is still pending. The estimated financial data has been reviewed by Vantiva’s Board of Directors and is currently...

Helios Consortium Offer for CAB

Written by Customer Service on March 27, 2026. Posted in Mergers And Acquisitions.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION Update Statement TORONTO, March 27, 2026 (GLOBE NEWSWIRE) — Introduction On 12 February 2026, the Helios Consortium announced a cash offer to acquire the entire issued and to be issued share capital of CAB Payments Holdings plc (“CAB Payments”), excluding CAB Payments shares already owned or controlled by Helios Fund III (the “Helios Offer Announcement”) (the “Helios Offer”). Under the terms of the Helios Offer, Eligible CAB Payments Shareholders would be entitled to receive US$1.15 in cash per existing CAB Payments share or the Partial Alternative Offer. The Helios Offer is supported by shareholders...

Novaturas Announces Changes in Chief Financial Officer Position

Written by Customer Service on March 27, 2026. Posted in Public Companies.

Novaturas Group announces a change in its executive team. As of March 27, Chief Financial Officer Auksė Kriaučiūnaitė is stepping down from her position. The company is currently conducting a search for a new candidate. “We are grateful to Auksė for her significant contribution and for taking on the responsibility of leading the finance team during a particularly dynamic period. We are glad to have worked together over these years and wish her the best of success in her future career,” says Novaturas CEO Ieva Galvydienė. The company is currently searching for a new Chief Financial Officer who will oversee operations across Lithuania, Latvia, and Estonia. During the selection process, CFO responsibilities will be ensured through internal resources. About the company The Novaturas Group is a tour operator offering the widest range of travel...

Novartis agrees to acquire Excellergy, Inc., building on allergy leadership with next-generation anti-IgE innovation

Written by Customer Service on March 27, 2026. Posted in Mergers And Acquisitions.

– Proposed acquisition strengthens Novartis immunology strategy in food allergy and other IgE-driven diseases – Lead asset Exl-111 builds on proven IgE biology with a differentiated mechanism designed to dissociate receptor-bound IgE and drive faster, deeper pathway suppression – Exl-111 would complement existing Novartis portfolio in allergy with potential to improve both symptom control and convenience Basel, March 27, 2026 – Novartis today announced that it has entered into an agreement to acquire Excellergy, Inc., a private biotech company developing next-generation anti-IgE therapies for IgE-driven diseases. The proposed acquisition adds Exl-111, a half-life extended, high-affinity anti-IgE antibody in Phase 1. The acquisition builds on deep Novartis expertise in IgE biology and a long-standing presence in...

IBA delivers strong FY 2025 results with solid execution in all segments

Written by Customer Service on March 27, 2026. Posted in Earnings Releases And Operating Results.

Read the entire full-year 2025 results press release hereLouvain-la-Neuve, Belgium, 27 March 2026 – IBA (Ion Beam Applications S.A.), today announces its consolidated results of 2025 financial year, with strong execution across the businesses. Robust commercial momentum, notably in Proton Therapy, resulted in a historic order intake and a new all-time high backlog. Delivered in line with guidance, the year marks continued progress in the execution of IBA’s strategic roadmap to the benefit of all its stakeholders.Record-high revenue and enhanced profitabilityNet sales rose 24% vs. 2024, to €620 million, thanks to well-executed backlog conversion in IBA Clinical (+44% net sales growth) Gross margin decreased to 32.2% vs. 33.7% in 2024, driven by less favorable equipment profitability mix (including legacy low-margin projects...

Excellergy to be acquired by Novartis for up to USD 2 billion to advance potentially first-in-class trifunctional effector cell response inhibitors

Written by Customer Service on March 27, 2026. Posted in Mergers And Acquisitions.

– Acquisition brings together Excellergy’s differentiated trifunctional allergic effector cell response inhibitors (ECRIs) and the development expertise of Novartis, with a total potential transaction value of up to $2 billion – – Exl-111 is a potentially first-in-class allergic trifunctional ECRI targeting the IgE axis and is currently in Phase 1 development – PALO ALTO, Calif., March 27, 2026 (GLOBE NEWSWIRE) — Excellergy, a biotechnology company developing a novel class of allergy therapeutics, today announced it will be acquired by Novartis in a transaction with a total potential value of up to $2 billion in upfront and milestone payments. The acquisition brings together Excellergy’s novel trifunctional ECRIs with the development expertise of Novartis. Exl-111 is a trifunctional ECRI designed to disarm allergic effector...

Year: 2026

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals